Adrien Julian
Poitiers, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Design and baseline findings of the NEODEM prospective cohort on early-onset neurodegenerative dementia.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: January 25, 2026
Biological Markers of Burnout Severity: A Systematic Review.
Journal: Stress and health : journal of the International Society for the Investigation of Stress
Published: November 03, 2025
Early positron emission tomography response-adapted treatment in low-risk diffuse large B-cell lymphoma: an open-label, multicenter, randomized, noninferiority phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 20, 2025
Early rise of glutamate-glutamine levels in mild cognitive impairment: Evidence for emerging excitotoxicity.
Journal: Journal of neuroradiology = Journal de neuroradiologie
Published: March 30, 2023
Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 20, 2023
Explaining the association between social and lifestyle factors and cognitive functions: a pathway analysis in the Memento cohort.
Journal: Alzheimer's research & therapy
Published: January 06, 2022
Attention-guided neural network for early dementia detection using MRS data.
Journal: Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society
Published: January 03, 2022
NFL strongly correlates with TNF-R1 in the plasma of AD patients, but not with cognitive decline.
Journal: Scientific reports
Published: January 29, 2021
Semantic loss marks early Alzheimer's disease-related neurodegeneration in older adults without dementia.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: June 09, 2020
How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.
Journal: BMJ open
Published: June 27, 2019
Blood Inflammatory Mediators and Cognitive Decline in Alzheimer's Disease: A Two Years Longitudinal Study.
Journal: Journal of Alzheimer's disease : JAD
Published: April 05, 2018
Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model.
Journal: PloS one
Published: February 23, 2018
Last Updated: 09/26/2026